Status:
COMPLETED
Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
University of Texas
Conditions:
Alcohol-Related Disorders
Cocaine-Related Disorders
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
End Date :
April 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000307
Start Date
April 1 2003
End Date
April 1 2007
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Health Science Center
Houston, Texas, United States, 77225